Innovation Hub Expert Panel
Dr. Andrew Walsh is a member of the Life Sciences at Cambridge Enterprise, the commercialisation arm of the University of Cambridge. He manages commercial opportunities that arise across the life sciences and has particular responsibility for Cambridge Enterprise’s engagement with the NHS. He has extensive experience in the identification, management and licensing of intellectual property and also been involved with the establishment of the spin-out companies, Definigen and XO1.
Dr. Arun Gupta is the Director of Postgraduate Education for Cambridge University Health Partners (CUHP) and has created a Multiprofessional Healthcare Education Board to bring together the key personnel from the four CUHP partner organisations with the aim of streamlining healthcare education. He is also the Director of Postgraduate Medical Education, Director of the Addenbrooke's Simulation Centre, and Consultant in Anaesthesia and Neurointensive Care at Cambridge University Hospitals, as well as an Associate Lecturer at the University of Cambridge.
Dr. Matija Krkovic is a Consultant Orthopaedic Trauma Surgeon, and Innovation lead for the Trauma & Orthopaedics Department at Cambridge University Hospitals. His main expertise is treatment of complex articular and periarticular fractures of lower and upper limb and treatment of bone infections.
Dr. Trevor Baglin has 20 years’ experience as an advisor to biotechnology and pharmaceutical companies and in recent years has successfully obtained venture capital funding for his own drug development programmes. His work is focused on the prevention and management of thrombosis and understanding molecular mechanisms of coagulation. He has published extensively (H-index 53) on genetic and environmental factors that predispose to thrombosis and laid the foundations for clinical decision rules leading to personalised patient risk profiling. His molecular studies identified a novel molecular basis for exosite interactions between proteases and inhibitors that define the specificity of inhibition, a finding that has led to novel antithrombotic strategies deploying enzyme modulation through exosite targeting, rather than standard active-site inhibition. This work was the foundation of drug development programmes and the establishment of single asset companies as a business model.
Dr. Peter Young is a critical care consultant in Kings Lynn. Over 20 years he has patented and developed nine innovations in cooperation with industry, NHS agencies and independently both in the medical and non-medical field. Areas of interest include anaesthesia, critical care, infection control and engineered solutions to patient safety problems. He actively encourages clinical innovators to engage with proactive Trusts to encourage a permissive and motivational approach to intellectual property.
Mr. Chris Constant has been an Orthopaedic and Trauma Surgeon and Specialist in Shoulder and Elbow Surgery at Addenbrooke’s Hospital since 1987 and is qualified as a Master in Medical Law specializing in consent, surgical error and clinical negligence. He has an extensive background in Clinical Research, Biomechanics and Shoulder Function. Since his early retirement from active surgical practice in 2006, as a result of severe arthritis in his hands, he has spent five years as Clinical Anatomist at the University of Cambridge and in 2012 became involved with the design team for the Centre, and in obtaining the Human Tissue Authority licence under which the Centre operates. As well as being a member of the Board, he is the HTA’s Designated Individual and Licensed Teacher at the Centre. ‘Mr C’ brings his clinical and surgical, legal, research and teaching skills to the Centre. (PHOTO)
Alison Ball was recently Vice President for R&D and Business Development for the microbiology division at Thermo Fisher Scientific prior to joining PA Consulting. During her time there, she built and led a team of over 130 scientists and engineers across a diverse range of scientific disciplines, including molecular biology, biochemistry, microbiology and proteomics as well as leading licensing, acquisition and integration activities for the division. She has held senior roles in sales, marketing, customer service and technology management, and has experience of a broad range of sectors including clinical diagnostics, food testing and biopharma production. She’s interested in the application of technology to solve customer problems and her focus for the past few years has been to acquire and develop technologies to create novel products for these customer segments.
John Pritchard Entrepreneur in Residence (Diagnostics and Devices) at University of Cambridge
John is a technically sophisticated and business-savvy professional with solid experience managing technology start-ups, state-of-the-art operations, cross-functional teams, IP assets, and organisational expansion projects to achieve competitive market advantages. Adept at spearheading technological innovations, new product delivery and commercialisation. Successful at delivering large-scale, mission-critical projects on time and under budget. Recognised industry pioneer (patents, invention disclosures, articles, conference papers) with over 30 years’ industry experience in diagnostics and bio technology, including advisory roles and 8 years’ board level experience.
Dr Ari Ercole Lecturer and Consultant Anaesthetist Ari became an anaesthetist after completing a PhD in physics at the University of Cambridge. He divides his time between clinical anaesthesia, teaching and research. His clinical interest is in resuscitation and trauma. He has a particular research focus on applications of systems biology in intensive care medicine and anaesthesia. He is particularly interested in measurement and modelling cerebral perfusion, oxygenation and metabolism after traumatic brain injury.
Dr Hans Hagen Chief Oprating Officer, CUHP Prior to joining CUHP, for the past nine years Dr Hagen has been at the Royal Society, most recently as its Head of Grants, where he brokered complex and novel funding schemes in sub-Saharan Africa. Hans originally trained as a researcher in the field of infectious tropical diseases, working in laboratories across the globe. Fifteen years ago he made the career switch to science funding. He worked for seven years at the Wellcome Trust where he set up a research fellowship to support scientists in the Central Europe and the Baltics. Fluent in German, French and English, Dr Hagen gained his doctorate at the Institute of Tropical Medicine, University of Tübingen, Germany, and Liverpool School of Tropical Medicine.
Mr Peter Jarritt Consultant Healthcare Scientist - Physical Sciences Cambridge University Hospitals NHS Foundation Trust and Chair BS70000 Standards Drafting Committee
Peter has extensive experience at Executive level in the delivery and development and Medical Physics and Clinical Engineering services. He acted as Professional Lead in the UK as President of the Institute of Physics and Engineering in Medicine. Recognized as a Fellow of the Institute of Physics and engineering in Medicine and Honorary Fellow of the Royal College of Physicians.
Stuart Thomson’s primary responsibility as Commercialisation Director at Health Enterprise East (HEE) is to manage the Innovation Portfolio and lead the Innovation Team to achieve successful protection, development and commercial exploitation of NHS Innovations covering medical devices, software, publications & training aids. He gained extensive experience within information and commercial analysis whilst working for GlaxoSmithKline. Stuart joined HEE in 2005 after completing his MSc in the Management of Intellectual Property at the Queen Mary, University of London. Stuart also holds a Diploma in European Intellectual Property and a BSc in Human Biosciences.
Dr David Pardoe: is Head of Growth Projects at MRC Technology working with research charities, academia and industrial partners to accelerate and promote new medicines to patients. He has an extensive 25 year background in developing new research tools and in medicinal chemistry, where he has been instrumental in delivering four candidate medicines to the clinic, including frovatriptan for the management of migraine. After leaving a management position at GlaxoSmithKline, David spent seven years working across the healthcare value chain in bringing new diagnostics, devices and drugs to patients.
Dr Sarah C Clarke: MA, MD, FRCP, FESC, FACC is a Consultant Cardiologist and the Clinical Director for Strategic Development at Papworth Hospital, Cambridge. She has a specialist interest in interventional cardiology. She has a track record in management, service innovation and implementation. She has a regional and national profile.
Dr Anne Blackwood: Chief Executive, Health Enterprise East Anne has overall responsibility for the management and performance of Health Enterprise East. Her specific roles include setting the strategic vision for the company, providing leadership to the rest of the team, developing the business plan and agreeing budgets. Anne has been actively involved in knowledge transfer and intellectual property management in the life sciences for over 10 years.
Professor McCaskie: is the Professor of Orthopaedic Surgery at the University of Cambridge. He is the Director of the Arthritis Research UK Tissue Engineering Centre, which brings together many centres; University of Cambridge, Newcastle University, the University of Aberdeen, Keele University/the Robert Jones and Agnes Hunt Hospital NHS Foundation Trust in Oswestry and the University of York. Funded by a core grant of £2.4 million over five years from Arthritis Research UK with a further £3.4 million pledged by the four participating universities. The centre brings together leading clinicians, engineers and biologists from research and clinical groups and to develop regenerative therapies for people with Osteoarthritis. Prof. McCaskie also led the Smart Step programme as part of Stage II UK Regenerative Medicine Platform. The aims to develop cell-free approaches to Osteoarthritis and establish a translational pipeline for their development. Prof. McCaskie facilitates Clinical Engagement as part of the Centre for Innovative Manufacturing in Medical Devices (MeDe) lead by Leeds University. He has worked for many years with the Bone and Joint Journal (formerly known as Journal of Bone and Joint Surgery B) and is currently Treasurer on the Council of Management
Dr Thomas Stone: Clinical Scientist - Head of Research and Development Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust
Dr Sonya Sireau: Cambridge Clinical Innovation, Cambridge University Hospitals NHS Foundation Trust
Mr James Tysome: Consultant ENT surgeon at Cambridge University
Hospitals NHS Foundation Trust
James treats patients with complex ear and skull base disease and is a member of multidisciplinary hearing implant and skull base teams. His postgraduate training included advanced otology and hearing implants at Guy’s and St.Thomas’ Hospitals, paediatric ENT at Great Ormond Street Hospital, a fellowship in neurotology and skull base surgery at Cambridge University Hospitals and working as a Clinical Instructor at Stanford University School of Medicine in California, USA, where he gained further experience of skull base surgery, cochlear implants and robotic surgery.
He read undergraduate medicine at Cambridge University and University College London. He has won many academic prizes over his career including the gold medal from the Royal Society of Medicine for his ranking as 1st in the examination taken by all ENT surgeons at the completion of their postgraduate training. He co-edited “ENT: an introduction and practical guide” and has been commissioned to co-edit “Dizziness: an introduction and practical guide”.
Ms Karen Livingstone Director of Partnerships & Industry Engagement, Eastern Academic Health Science Network:
Karen Livingstone is the Director of Partnerships and Industry Engagement for the Eastern Academic Health Science Network and the National Director for SBRI Healthcare. She is supporting the Network to develop its role in economic development and wealth creation.
Karen also leads the Small Business Research Initiative (SBRI) for NHS England where small enterprises are funded to develop technology solutions for healthcare problems and supports the work of the Innovations team in their relationships with industry.
Professor Stefan Scholtes: Dennis Gillings Professor of Health Management and Academic Director of the Centre for Health Leadership & Enterprise, University of Cambridge.
Stefan is an associate editor of Operations Research andMathematics of Operations Research, and was previously associate editor of the SIAM Journal on Optimization and the IMA Journal of Numerical Analysis.Stefan has taught operations research at the University of Karlsruhe in Germany and in Cambridge's Engineering Department, where he retains a courtesy faculty position. Prior to his appointment to the Gillings Chair of Health Management, he was Professor of Management Science at Cambridge Judge Business School. He has held visiting positions at Stanford, MIT and London Business School and has spent a six-month sabbatical with Cambridge University Hospitals NHS Foundation Trust.
Professor John Clarkson Engineering Design Centre, University of Cambridge
John Clarkson has worked at the Department of Engineering since 1995 following a seven-year spell with PA Consulting Group's Technology Division where he was Manager of the Advanced Process Group. He was appointed director of the Engineering Design Centre in 1997 and a University Professor in 2004. At PA John gained wide experience of product development with a particular focus on the design of medical equipment and high-integrity systems, where clients required a risk-based systems approach to design to ensure timely delivery of safe systems. John is directly involved in the teaching of design at all levels of the undergraduate course. His research interests are in the general area of engineering design, particularly the development of design methodologies to address specific design issues, for example, process management, change management, healthcare design and inclusive design. As well as publishing over 500 papers, he has written and edited a number of books on medical equipment design, inclusive design and process management.
Dr Stephen T Webb: Was appointed as Consultant in Anaesthesia and Intensive Care at Papworth Hospital NHS Foundation Trust Cambridge, the largest adult cardiothoracic centre in the UK, in 2008. His clinical, educational and research interests lie in cardiothoracic anaesthesia and cardiothoracic intensive care. He also has a major interest in clinical audit, quality improvement and patient safety. At Papworth Hospital, his roles include Lead Clinician for Clinical Governance and Staff Governor representing Doctors. At a regional level, he is a Member of the East of England Clinical Senate Council and the Faculty of Medical Leadership & Management (FMLM) Regional Quality Lead for Midlands & East. He is currently Royal College of Physicians' (RCP) Clinical Leader in Quality Improvement
responsible for East of England & East Midlands. He is also a Member of the National Institute of Health & Care Excellence (NICE) Accreditation Advisory Committee and member of the Intensive Care Society (ICS) Council.